Your browser doesn't support javascript.
loading
Screening for Fabry Disease in Japanese Patients with Young-Onset Stroke by Measuring α-Galactosidase A and Globotriaosylsphingosine.
Kinoshita, Naoto; Hosomi, Naohisa; Matsushima, Hayato; Nakamori, Masahiro; Yagita, Yoshiki; Yamawaki, Takemori; Torii, Tsuyoshi; Kitamura, Takeshi; Sueda, Yoshimasa; Shimomura, Ryo; Araki, Mutsuko; Nezu, Tomohisa; Aoki, Shiro; Ishii, Satoshi; Maruyama, Hiroki; Matsumoto, Masayasu; Maruyama, Hirofumi.
Afiliação
  • Kinoshita N; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Hosomi N; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan. Electronic address: nhosomi@hiroshima-u.ac.jp.
  • Matsushima H; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan; Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan.
  • Nakamori M; Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan.
  • Yagita Y; Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Japan.
  • Yamawaki T; Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Torii T; Department of Neurology, National Hospital Organization Kure Medical Center, Kure, Japan.
  • Kitamura T; Department of Neurology, Chugoku Rosai Hospital, Kure, Japan.
  • Sueda Y; Department of Neurology, National Hospital Organization Higashihiroshima Medical Center, Higashihiroshima, Japan.
  • Shimomura R; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Araki M; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Nezu T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Aoki S; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Ishii S; GlycoPharma Corporation, Oita, Japan.
  • Maruyama H; Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Matsumoto M; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Maruyama H; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
J Stroke Cerebrovasc Dis ; 27(12): 3563-3569, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30201457

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esfingolipídeos / Glicolipídeos / Hemorragia Cerebral / Isquemia Encefálica / Doença de Fabry / Alfa-Galactosidase / Acidente Vascular Cerebral Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Stroke Cerebrovasc Dis Assunto da revista: ANGIOLOGIA / CEREBRO Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esfingolipídeos / Glicolipídeos / Hemorragia Cerebral / Isquemia Encefálica / Doença de Fabry / Alfa-Galactosidase / Acidente Vascular Cerebral Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Stroke Cerebrovasc Dis Assunto da revista: ANGIOLOGIA / CEREBRO Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão